Back to News
Market Impact: 0.45

CVNA vs. ABG: Which Auto Retailer Should You Park in Your Portfolio?

CVNAABG
Automotive & EVCompany FundamentalsCorporate EarningsTechnology & InnovationConsumer Demand & RetailM&A & RestructuringAnalyst InsightsMarket Technicals & Flows
CVNA vs. ABG: Which Auto Retailer Should You Park in Your Portfolio?

Carvana (CVNA) has demonstrated a significant operational turnaround, reporting a record $488 million adjusted EBITDA with 11.5% margins and 46% retail sales growth, positioning it as a profitability leader despite its over $5 billion debt load. In contrast, Asbury Automotive (ABG), a diversified traditional dealer with a growing digital platform (Clicklane sales up 13%), faces near-term profitability pressures from rising SG&A costs and substantial capital expenditures, resulting in an adjusted EBITDA margin below 6%. The analysis suggests CVNA is the more compelling growth-oriented investment, while ABG remains a cautious hold.

Analysis

The auto retail sector presents a clear divergence between Carvana's (CVNA) high-growth, digital-first model and Asbury Automotive's (ABG) traditional, diversified approach. Carvana has demonstrated a significant operational turnaround, shifting from a high-burn disruptor to a profitability leader. The company reported a 46% year-over-year increase in retail unit sales, a record adjusted EBITDA of $488 million, and an industry-leading adjusted EBITDA margin of 11.5% in its last quarter, substantially outpacing competitors. This performance, driven by efficiency gains and a gross profit per unit of $6,938, has fueled a 70% year-to-date rally in its stock. The primary risk factor remains its substantial long-term debt exceeding $5 billion. In contrast, Asbury Automotive is pursuing a hybrid strategy, supplementing its physical dealerships with the Clicklane digital platform, which saw unit sales grow 13% year-over-year. ABG's growth is heavily reliant on acquisitions, with the recent Herb Chambers deal expected to add $3 billion in annualized revenues. However, ABG faces significant headwinds, including rising SG&A costs (63.9% of gross profit), an adjusted EBITDA margin below 6%, deferred revenue pressures from prior acquisitions, and a high annual capital expenditure plan of $250 million, which is expected to constrain free cash flow. This operational drag is reflected in its modest 7% year-to-date stock performance and significantly lower forward sales multiple of 0.27 compared to CVNA's 3.67.